FDA Approval Outcome for New Therapeutic
Resolves: FDA approval of a new drug developed by SGMOQ
sec_filing· Regulatory Event
FDA Approval Outcome for New Therapeutic
Market overview
Derived from SANGAMO THERAPEUTICS, INC (SGMOQ) (CIK 0001001233) 8-K filing analysis
Regulatory Event prediction market
- Implied probability (Yes)
- 65%
- Closes
- 2027-09-21
About this prediction
Resolution criteria
FDA approval of a new drug developed by SGMOQ
More Regulatory Event markets
No one's made a Conviction call on this yet. Be the first to call it →
Loading…